Resilience of a FIT screening programme against screening fatigue: a modelling study

被引:13
作者
Greuter, Marjolein J. E. [1 ]
Berkhof, Johannes [1 ]
Canfell, Karen [2 ,3 ]
Lew, Jie-Bin [2 ,4 ]
Dekker, Evelien [5 ]
Coupe, Veerle M. H. [1 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, POB 7057 MF F Wing, NL-1007 MB Amsterdam, Netherlands
[2] NSW Canc Council, Canc Res Div, Sydney, NSW, Australia
[3] Univ Sydney, Sydney Med Sch, Sch Publ Hlth, Sydney, NSW, Australia
[4] Univ New South Wales, Fac Med, Prince Wales Clin Sch, Sydney, NSW, Australia
[5] Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
基金
英国医学研究理事会;
关键词
Colorectal cancer; Screening; Participation; OCCULT BLOOD-TESTS; COLORECTAL-CANCER; IMMUNOCHEMICAL TEST; 3; ROUNDS; ADENOMA; PARTICIPATION; COLONOSCOPY; INTERVAL; YIELD; RISK;
D O I
10.1186/s12889-016-3667-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Repeated participation is important in faecal immunochemical testing (FIT) screening for colorectal cancer (CRC). However, a large number of screening invitations over time may lead to screening fatigue and consequently, decreased participation rates. We evaluated the impact of screening fatigue on overall screening programme effectiveness. Methods: Using the ASCCA model, we simulated the Dutch CRC screening programme consisting of biennial FIT screening in individuals aged 55-75. We studied the resilience of the programme against heterogeneity in screening attendance and decrease in participation rate due to screening fatigue. Outcomes were reductions in CRC incidence and mortality compared to no screening. Results: Assuming a homogenous 63 % participation, i.e., each round each individual was equally likely to attend screening, 30 years of screening reduced CRC incidence and mortality by 39 and 53 %, respectively, compared to no screening. When assuming clustered participation, i.e., three subgroups of individuals with a high (95 %), moderate (65 %) and low (5 %) participation rate, screening was less effective; reductions were 33 % for CRC incidence and 43 % for CRC mortality. Screening fatigue considerably reduced screening effectiveness; if individuals refrained from screening after three negative screens, model-predicted incidence reductions decreased to 25 and 18 % under homogenous and clustered participation, respectively. Figures were 34 and 25 % for mortality reduction. Conclusions: Screening will substantially decrease CRC incidence and mortality. However, screening effectiveness can be seriously compromised if screening fatigue occurs. This warrants careful monitoring of individual screening behaviour and consideration of targeted invitation systems in individuals who have (repeatedly) missed screening rounds.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 32 条
[1]   Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics [J].
Allison, James E. ;
Sakoda, Lori C. ;
Levin, Theodore R. ;
Tucker, Jo P. ;
Tekawa, Irene S. ;
Cuff, Thomas ;
Pauly, Mary Pat ;
Shlager, Lyle ;
Palitz, Albert M. ;
Zhao, Wei K. ;
Schwartz, J. Sanford ;
Ransohoff, David F. ;
Selby, Joseph V. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (19) :1462-1470
[2]  
[Anonymous], 1986, BMJ-BRIT MED J, V293, P659
[3]  
Australian government - department of health, 2005, NAT CERV SCREEN PROG
[4]   Colorectal cancer [J].
Brenner, Hermann ;
Kloor, Matthias ;
Pox, Christian Peter .
LANCET, 2014, 383 (9927) :1490-1502
[5]   Cervical Screening at Age 50-64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study [J].
Castanon, Alejandra ;
Landy, Rebecca ;
Cuzick, Jack ;
Sasieni, Peter .
PLOS MEDICINE, 2014, 11 (01)
[6]   Risk of invasive cervical cancer after three consecutive negative Pap smears [J].
Coldman, A ;
Phillips, N ;
Kan, L ;
Matisic, J ;
Benedet, L ;
Towers, L .
JOURNAL OF MEDICAL SCREENING, 2003, 10 (04) :196-200
[7]   High Rate of Advanced Adenoma Detection in 4 Rounds of Colorectal Cancer Screening With the Fecal Immunochemical Test [J].
Crotta, Sergio ;
Segnan, Nereo ;
Paganin, Simona ;
Dagnes, Bruna ;
Rosset, Roberto ;
Senore, Carlo .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (06) :633-638
[8]   Colorectal cancer [J].
Cunningham, David ;
Atkin, Wendy ;
Lenz, Heinz-Josef ;
Lynch, Henry T. ;
Minsky, Bruce ;
Nordlinger, Bernard ;
Starling, Naureen .
LANCET, 2010, 375 (9719) :1030-1047
[9]   Immunochemical Fecal Occult Blood Testing Is Equally Sensitive for Proximal and Distal Advanced Neoplasia [J].
de Wijkerslooth, T. R. ;
Stoop, E. M. ;
Bossuyt, P. M. ;
Meijer, G. A. ;
van Ballegooijen, M. ;
van Roon, A. H. C. ;
Stegeman, I. ;
Kraaijenhagen, R. A. ;
Fockens, P. ;
van Leerdam, M. E. ;
Dekker, E. ;
Kuipers, E. J. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (10) :1570-1578
[10]   Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening [J].
Denters, M. J. ;
Deutekom, M. ;
Bossuyt, P. M. ;
van Rijn, A. F. ;
Fockens, P. ;
Dekker, E. .
CANCER EPIDEMIOLOGY, 2013, 37 (03) :330-335